Cargando…
Prognostic value of aberrant promoter hypermethylation of tumor-related genes in early-stage head and neck cancer
Staging and pathological grading are useful, but imperfect predictors of recurrence in head and neck squamous cell carcinoma (HNSCC). Accordingly, molecular biomarkers that predict the risk of recurrence are necessary to improve clinical outcomes. The methylation statuses of the promoters of 11 tumo...
Autores principales: | Misawa, Kiyoshi, Mochizuki, Daiki, Imai, Atsushi, Endo, Shiori, Mima, Masato, Misawa, Yuki, Kanazawa, Takeharu, Carey, Thomas E., Mineta, Hiroyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041966/ https://www.ncbi.nlm.nih.gov/pubmed/27027429 http://dx.doi.org/10.18632/oncotarget.8317 |
Ejemplares similares
-
Aberrant Epigenetic Regulation in Head and Neck Cancer Due to Distinct EZH2 Overexpression and DNA Hypermethylation
por: Mochizuki, Daiki, et al.
Publicado: (2018) -
Association of TET3 epigenetic inactivation with head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2018) -
The neuropeptide genes SST, TAC1, HCRT, NPY, and GAL are powerful epigenetic biomarkers in head and neck cancer: a site-specific analysis
por: Misawa, Kiyoshi, et al.
Publicado: (2018) -
Genes encoding neuropeptide receptors are epigenetic markers in patients with head and neck cancer: a site-specific analysis
por: Misawa, Kiyoshi, et al.
Publicado: (2017) -
Epigenetic silencing of SALL3 is an independent predictor of poor survival in head and neck cancer
por: Misawa, Kiyoshi, et al.
Publicado: (2017)